MNNGF (Baijin Life Science Holdings) Long-Term Debt: $8.01 Mil (As of Sep. 2025)


MNNGF Baijin Life Science Holdings Ltd MNNGF
26 GF Score
Price $0.08
GF Value $0.05
! 5 Warning Signs
View Full Analysis

What is Baijin Life Science Holdings Long-Term Debt?

Baijin Life Science Holdings MNNGF 26 Long-Term Debt is $8.01 Mil as of Sep. 2025. GuruFocus rates MNNGF with a GF Score™ of 26/100 and a GF Value™ of $0.05. The stock has 5 warning signs investors should review.

Baijin Life Science Holdings's Long-Term Debt for the quarter that ended in Sep. 2025 was $8.01 Mil.

Baijin Life Science Holdings's quarterly Long-Term Debt increased from Sep. 2024 ($5.10 Mil) to Mar. 2025 ($9.69 Mil) but then declined from Mar. 2025 ($9.69 Mil) to Sep. 2025 ($8.01 Mil).

Baijin Life Science Holdings's annual Long-Term Debt increased from Mar. 2023 ($0.00 Mil) to Mar. 2024 ($5.08 Mil) and increased from Mar. 2024 ($5.08 Mil) to Mar. 2025 ($9.69 Mil).

Baijin Life Science Holdings  (OTCPK:MNNGF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Baijin Life Science Holdings Long-Term Debt Related Terms

Baijin Life Science Holdings Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Baijin Life Science Holdings's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baijin Life Science Holdings Long-Term Debt Chart

Baijin Life Science Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 5.08 9.69 0.00

Baijin Life Science Holdings Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.08 5.10 9.69 8.01 0.00
MNNGF
26GF Score
Baijin Life Science Holdings Ltd MNNGF
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $8.01 Mil mean?
Baijin Life Science Holdings (MNNGF) has a Long-Term Debt of $8.01 Mil as of Sep. 2025.
Is Baijin Life Science Holdings' Long-Term Debt too high?
Baijin Life Science Holdings' current Long-Term Debt is $8.01 Mil. Overall, Baijin Life Science Holdings has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Long-Term Debt compare to TPR?
Baijin Life Science Holdings' Long-Term Debt of $8.01 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Retail - Cyclical company?
A good Long-Term Debt depends on the Retail - Cyclical industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Baijin Life Science Holdings's current Long-Term Debt is $8.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Long-Term Debt of $8.01 Mil. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 50% above its estimated fair value. The current Long-Term Debt is $8.01 Mil. Baijin Life Science Holdings' overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Long-Term Debt is $8.01 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?

Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued. The current stock price of $0.08 is trading 50% above its estimated GF Value™ of $0.05.

Key valuation signals for MNNGF:

  • Long-Term Debt: $8.01 Mil
  • GF Value™: $0.05 vs. price of $0.08 (50% above fair value)
  • GF Score™: 26/100 with 5 warning signs

No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Baijin Life Science Holdings Business Description

Other Exchanges 01466:Hong Kong
Address 66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
26GF Score

Get the complete analysis for MNNGF

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.05
GF Value